At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Sorted Descending Price Range
Jul 21, 2008 bloch stephen m Director Automatic Sell 7,600 14.47
Feb 3, 2009 palling david Officer Automatic Sell 7,500 10.00
Jun 26, 2009 palling david Officer Automatic Sell 7,498 10.00
Feb 15, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 6,900 10.47 - 10.50
Feb 15, 2008 topper james n Director Buy 6,900 10.47 - 10.50
Feb 22, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 6,614 9.67 - 10.08
Feb 22, 2008 topper james n Director Buy 6,614 9.67 - 10.08
Jul 15, 2009 crowley john f Officer Automatic Sell 6,500 10.69
Jun 5, 2007 barkas alexander e Director Sell 6,427 15.00
Jun 5, 2007 prospect venture partners ii lp Beneficial Owner (10% or more) Sell 6,427 15.00
Jun 5, 2007 barris peter j Beneficial Owner (10% or more) Sell 6,408 15.00
Jun 5, 2007 kramlich c richard Beneficial Owner (10% or more) Sell 6,408 15.00
Jun 5, 2007 new enterprise associates 11 lp Beneficial Owner (10% or more) Sell 6,408 15.00
Jun 5, 2007 newhall charles w iii Beneficial Owner (10% or more) Sell 6,408 15.00
Jun 5, 2007 perry mark w Beneficial Owner (10% or more) Sell 6,408 15.00
Jan 31, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 6,215 9.38 - 9.80
Jan 31, 2008 topper james n Director Buy 6,215 9.38 - 9.80
Aug 4, 2008 crowley john f Officer Automatic Sell 6,200 15.22 - 15.27
Jul 7, 2009 crowley john f Officer Automatic Sell 6,200 11.15 - 11.69
Feb 13, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 6,200 10.10 - 10.43
Showing 141-160 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy